|
Contributed
Papers: Oral Presentations
Vaccines
NON-INTERFERENCE
OF INOVOCOXTM, A LIVE COCCIDIAL OOCYST VACCINE, WITH
MAREK’S DISEASE VACCINE OR BURSAPLEX®, A LIVE
BURSAL DISEASE VACCINE, AFTER IN OVO ADMINISTRATION
V. W. Doelling, R. M.
Poston, A. Martin, L. M. Charniga, L. K. Griffin. D.
B. Link and A. P. Avakian
Embrex, Inc., P.O. Box 13989, Research Triangle Park,
NC 27709
vdoelling@embrex.com
Studies
were conducted to determine the compatibility of Inovocox™,
a live coccidiosis vaccine, with other in ovo vaccines.
Safety and efficacy of Inovocox and a commercial live
Marek’s Disease (MD) HVT-SB1 vaccine or Bursaplex®,
a commercial live infectious bursal disease (IBD) vaccine,
was determined after co-administration in ovo. Inovocox
consists of four strains of coccidia including Eimeria,
E. tenella, and two strains of E.
maxima. For each study, in ovo treatments included
sham-vaccination with diluent, Inovocox alone, MD or
IBD vaccine alone, or Inovocox combined with MD or IBD
vaccine. Each vaccine preparation was administered in
100 ul of Marek’s diluent at 18 days of embryonation
to broiler or SPF eggs. To test Inovocox efficacy, broilers
were placed in floor pens and challenged with mixed
Eimeria strains at 21 days of age. Efficacy was
assessed by weight gain and intestinal lesion scores
at six days post challenge. Viral vaccine efficacy was
tested in SPF birds in isolation units. Groups receiving
MD or IBD viral challenge were monitored for challenge-related
mortality. Birds were also necropsied for relevant gross
lesions at 49 days post challenge for MD and 3 days
post challenge for IBD. There were no differences in
percent hatch and no treatment related mortalities in
any treatment group. Weight gain and lesion scores in
the Inovocox vaccinated treatment groups demonstrated
significant protection when Inovocox was administered
alone or in combination with MD vaccine or Bursaplex.
Both the MD and Bursaplex vaccines demonstrated significant
protection when administered with Inovocox or alone.
Together, these results demonstrate that co-administration
of Inovocox with either MDV or Bursaplex is safe and
does not interfere with vaccine efficacy.
back | print
|
|